Indian Journal of Pharmacy and Pharmacology

Print ISSN: 2393-9079

Online ISSN: 2393-9087


Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and more...

Powered by

Journal Keywords

  • Pharmacy
  • Pharmacology
  • Clinical Pharmacology
  • Experimental Pharmacology
  • Clinical trials
  • Drug Delivery
  • Drug Targeting
  • Experimental Pharmacy
  • Experimental Preparation
  • Pharmacy Practice
  • Pharmacy Education.

About Journal

Indian Journal of Pharmacy and Pharmacology (IJPP) open access, peer-reviewed quarterly journal publishing since 2014 and is published under auspices of the Innovative Education and Scientific Research Foundation (IESRF), aim to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. IESRF is dedicated to the transfer of technology and research by publishing scientific journals, research content, providing professional’s membership, and conducting conferences, seminars, and award programs.

With the aim of faster and better dissemination of knowledge, we will be publishing the article ‘Ahead of Print’ immediately on acceptance. In addition, the journal would allow free access (Open Access) to its contents, which is likely to attract more readers and citations to articles published in IJPP.

Manuscripts must be prepared in accordance with “Uniform requirements for Manuscripts submitted to Biomedical Journals” as per guidelines by the International Committee of Medical Journals Editors (Updated December 2019). The uniform requirements and specific requirements of IJPP are mentioned below. Before sending a manuscript contributors are requested to check for the author guidelines are available from the website of the journal ( or directly from (Innovative Pre-Publication Portal) manuscript submission website

Aims and Scope

Indian Journal of Pharmacy and Pharmacology ISSN 2393-9079 is a peer-reviewed, open-access journal that publishes peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trials studies in the rapidly developing field of Pharmacy, Pharmacology, Clinical Pharmacology, Experimental Pharmacology, Clinical trials, Drug Delivery, Drug Targeting, Experimental Pharmacy, Pharmaceutical Preparations, Pharmacy Practice, Pharmacy Education.

The aims of the journal include the following:

• To publish research on all aspects of drug development and production, drug delivery or targeting, from initial concept to potential therapeutic application and final relevance in clinical use, and the evaluation of drugs and pharmaceutical products.

• To publish articles covering research on the molecular mechanistic understanding of drug delivery and drug delivery systems, including physical and pharmaceutical chemistry, biochemistry and biophysics, molecular and cellular biology, and polymer and materials science and all aspects of developments in pharmaceutical research, from animal studies to early clinical investigation, biological therapy, including gene therapy, gene transfer technologies, therapeutic peptides, proteins, vaccines and antibodies, and cell- and tissue-based therapies, transport routes, and mechanisms, including efflux proteins and multi-drug resistance.

• The journal's scope includes therapeutics in many areas: pulmonary-allergy, dermatology, gastrointestinal, arthritis, infectious disorders, endocrine and metabolic, central and peripheral nervous system, cardiovascular and renal, and oncology.

• The Key areas of interest are pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to full clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Papers concerned with the effects of common food ingredients and standardized plant extracts, including commercial products, are particularly relevant, as are mechanistic studies on isolated natural products.

• IJPP keeps pace with new research on how new technologies may optimize drug action, and attention is given to understanding and improving drug interactions in the body. At the same time, the journal maintains its established and well-respected core strengths in pharmaceutics and drug delivery, experimental and clinical pharmacology, pharmaceutics, biopharmaceutics, pharmaceutical chemistry, pharmacognosy, pharmacology, pharmaceutical analysis, pharmacy practice, and clinical and hospital pharmacy. 

• Its audience includes pharmaceutical scientists, pharmacologists, regulatory professionals, formulation scientists, academicians, Ph.D. and Post-Doctoral Research Scholars, process chemists, and analytical chemists. IJPP also reports on the state of affairs in pharmacy and pharmacology, with politics and policy from pharmacy leaders and professional and industry events and conferences.

• Journal of Pharmacy and Pharmacology follows the 'Creative Commons Attribution License and scholars' and open access publishing policies. Readers can freely access the published articles online with a unique Digital Objective Identifier (DOI) provided by Cross Ref.

Indexing and Abstracting Information
Index Copernicus, Google Scholar, Indian Science Abstracts, National Science Library, J- gate, ROAD, CrossRef, Microsoft Academic, Indian Citation Index (ICI).

Journal Ethics

Journal is committed to upholding the highest standards of ethical behavior at all stages of publication. We strictly adhere to the industry associations such as the Committee on Publication Ethics (COPE)International Committee of Medical Journal Editors (ICMJE), and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. Our specific policies regarding duplicate publication, conflict of interest, patient consent, etc., Please visit the editor guidelines


IJPP is committed to publishing original studies and timely reviews that have neither been published nor are under consideration elsewhere. iThenticate™ All the submitted manuscripts (MSs) are subjected to the CrossCheck, and the plagiarized materials will incur the “Plagiarism Sanctions". Submitted MSs, which are found to be published or under review elsewhere, will be sustained and experience the “Duplicated Publication Sanctions” and if any submitted manuscripts either fabricated or falsified data, including the manipulation of images, will confront the “Data Fabrication/Falsification Sanctions.”

Digital Archiving
Innovative Publication has a primary partnership with CLOCKSS Archive to provide long-term digital preservation.
CLOCKSS is a collaborative project between 14 leading publishers and 34 institutional libraries to provide a ‘dark archive’ that guarantees long -term preservation and access. It uses the LOCKS technology to archive all material from participating publishers.

Ahead of Print Policy
Articles published online under the “Ahead of Print” model are considered published and can be cited and quoted using DOI as the reference source. Innovative Publication has a policy that changes WILL NOT be made after the publication of an article unless an accepted procedure for making corrections to the scientific record is followed.


Open Access (OA) Publication and Creative Commons Licensing
IJPP is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. More info

Open Access (OA) provides a sustainable funding model for scientific communications while ensuring the widest possible access to research. Wider audiences and new readers can now freely access research articles without the hassle of payment or institutional support, which may be required to cover the expensive subscription. Open Access allows readers to use articles and data in new ways, including practices like meta-analysis and text mining, which reveal trends in science that would not be obvious at the level of individual articles.

Revenue Sources
Indian Journal of Pharmacy and Pharmacology is a self-financed open access journal, which is published in both online and print versions. Article publication charges levied to authors are the only source of income that is utilized in maintaining the administrative and the print cost. Also, the very least part of revenue comes from advertisements and subscriptions.

The APC is based on an adjusted scale, providing reduced rates for low- and middle-income countries on the publication charges. Operating expense including the cost of web presence, print version, pre-press preparations, and staff salaries is supported by above-mentioned resources.

IESRF has outsourced all pre-publication, publication, and post-publication processes to the publisher, including APC management.

Please visit for APC details


Advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place to ensure the integrity of the journal and its content:

IJPP does not endorse any product or service marked as an advertisement or promoted by a sponsor. Editorial content is not compromised by commercial or financial interests, or by any specific arrangements with advertising clients or sponsors. All advertisements and commercially sponsored publications are independent of editorial decisions. Advertisers will never be shown any manuscripts or other content prior to publication.

Once an advertisement has been deployed online, it will be withdrawn from the journal site at any time if the Editor(s)-in-Chief or Publisher requests its removal. All advertisements for drug-specific campaigns should encourage correct and rational use and must not be misleading.

Please send any complaints about advertising to

IP Innovative Publication Private Limited
Innovative Publication is a part of IP Innovative Publication Private Limited, which is one of the reputed publishers in India, with more than 200+ books and 49+ journals in medical, dental, nursing, and pharmacy subjects in its portfolio. Our customers include professionals, institutions, and students of medicine, nursing, allied health, and pharmacy.  Researchers, students, scholars, clinicians, and other healthcare professionals access Innovative journals from around the globe to educate themselves about new and innovative discoveries and to improve patient care.

Innovative was founded in April 2011 and has become a well-respected medical publisher in India that fully supports many of the popular open access models through its peer-review management system. The innovative Open Access policy has resulted in more than five thousand articles being downloaded daily from its wide spectrum of journals.

Innovative has proven itself a leading publisher in India and has now established its global presence in more than 20 countries worldwide. From humble beginnings, it has grown into a publishing company with annual revenue of 2.50 crore rupees in the last financial year (2020-2021).

Innovative Specialization
Print and Online Scholarly Publisher, Peer-review system, Specialized in Medical, Dental, Nursing, and Pharmacy books and Journals as an Open Access (OA) Publisher.

Open Abstract (Increase article citation) Wiki in hindi